{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:30:36Z","timestamp":1783006236985,"version":"3.54.5"},"reference-count":32,"publisher":"Termedia Sp. z.o.o.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesiol Intensive Ther"],"DOI":"10.5114\/ait.2019.87646","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T14:21:58Z","timestamp":1568211718000},"page":"169-177","source":"Crossref","is-referenced-by-count":11,"title":["Malignant hyperthermia \u2013 what do we know in 2019?"],"prefix":"10.5114","volume":"51","author":[{"given":"Agnieszka","family":"Cieniewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Trzebicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Mayzner-Zawadzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kostera-Pruszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rados\u0142aw","family":"Owczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"ref-1384115","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0310-1"},{"key":"ref-1384116","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3181c6b9b2"},{"key":"ref-1384117","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S47632"},{"key":"ref-1384118","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318167aee2"},{"key":"ref-1384119","unstructured":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (2018) S1-Leitlinie: Therapie dermalignen Hyperthermie. An\u00e4sth Intensivmed 2018; 59: 204-208."},{"key":"ref-1384120","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001878"},{"key":"ref-1384121","doi-asserted-by":"crossref","unstructured":"Britt BA, Kalow W. Malignant hyperthermia: a statistical review. Can Anaesth Soc J 1970; 17: 293-315.","DOI":"10.1007\/BF03004694"},{"key":"ref-1384122","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318200197d"},{"key":"ref-1384123","unstructured":"Mayzner-Zawadzka E. Current status of malignant hyperthermia in Poland. 23th Annual Meeting of the European Malignant Hyperthermia Group in Leipzig 2004."},{"key":"ref-1384124","doi-asserted-by":"crossref","unstructured":"Sambuughin N, Holley H, Muldoon S, et al. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population. Anesthesiology 2005; 102: 515-521. doi: 10.1097\/ 00000542-200503000-00007.","DOI":"10.1097\/00000542-200503000-00007"},{"key":"ref-1384125","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2001.590306.x"},{"key":"ref-1384126","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32370"},{"key":"ref-1384127","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S47632"},{"key":"ref-1384128","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeq243"},{"key":"ref-1384129","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2016.07.018"},{"key":"ref-1384130","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31818958e5"},{"key":"ref-1384131","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000062"},{"key":"ref-1384132","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes"},{"key":"ref-1384133","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199404000-00008"},{"key":"ref-1384134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044"},{"key":"ref-1384135","unstructured":"Malignant Hyperthermia Association of the United States; www.mhaus. org."},{"key":"ref-1384136","unstructured":"European Malignant Hyperthermia Group; www.emhg.org."},{"key":"ref-1384137","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aev225"},{"key":"ref-1384138","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001877"},{"key":"ref-1384139","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03370060083024"},{"key":"ref-1384140","doi-asserted-by":"crossref","unstructured":"Kim TW, Nemergut ME. Preparation of modern anesthesia workstations for malignant hyperthermia susceptible patients: A review of past and present practice. Anesthesiology 2011; 114: 205-212.","DOI":"10.1097\/ALN.0b013e3181ee2cb7"},{"key":"ref-1384141","doi-asserted-by":"crossref","unstructured":"Sessler DI. Temperature monitoring and perioperative thermoregulation. Anesthesiology 2008; 109: 318-338.","DOI":"10.1097\/ALN.0b013e31817f6d76"},{"key":"ref-1384142","doi-asserted-by":"crossref","unstructured":"Larach MG, Brandom BW, Allen GC, et al. Malignant hyperthermia deaths related toinadequate temperature monitoring, 2007-2012: a report from the North Americanmalignant hyperthermia registry of the malignant hyperthermia association of theUnited States. Anesth Analg 2014; 119: 1359-1366.","DOI":"10.1213\/ANE.0000000000000421"},{"key":"ref-1384143","doi-asserted-by":"crossref","unstructured":"Barnes C, Stowell KM, Bulger T, Langton E, Pollock N. Safe duration of postoperative monitoring for malignant hyperthermia patients administered non-triggering anaesthesia: an update. Anaesth Intensive Care 2015; 43: 98-104.","DOI":"10.1177\/0310057X1504300115"},{"key":"ref-1384144","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009115"},{"key":"ref-1384145","unstructured":"ClinicalTrials.gov Identifier: NCT0256159."},{"key":"ref-1384146","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0b013e32833b1adf"}],"container-title":["Anaesthesiology Intensive Therapy"],"original-title":[],"link":[{"URL":"https:\/\/www.ait-journal.com\/pdf-201272-122021","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ait-journal.com\/pdf-201272-122021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T11:07:28Z","timestamp":1743073648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ait-journal.com\/Malignant-hyperthermia-what-do-we-know-in-2019-,201272,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["201272"],"URL":"https:\/\/doi.org\/10.5114\/ait.2019.87646","relation":{},"ISSN":["1642-5758","1731-2531"],"issn-type":[{"value":"1642-5758","type":"print"},{"value":"1731-2531","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]}}}